Obesity, diabetes treatments fuel Eli Lilly growth and spark bidding war
The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker. Lilly said Thursday that its top-selling drugs, Mounjaro and Zepbound, brought in more than $10 bi
(Financial Post, 2025-10-30T14:41:11Z)